us to rethink patent law. The paper splits up this question by looking at two facets in more depth – patentability and … patentability and infringement theory and practice and their possible interpretation in a 3D printing context, a set of different … printing does not upset patentability theory in general: it does not challenge prevailing concepts of patentable subject matter …

: adopting a more receptive attitude toward compulsory licensing; examining the books of patent holders, including pharmaceutical …

an innovation rewarding institution. According to our analysis, pharma patents have constituted legal barriers to protect … witnessed by the fact that patent applications are very skewed in the covered trade names and patent thickness expands over time … pharmaceutical firms, between patent portfolio and profit margins. …

the proliferation of immunity-escaping variants. Therefore governmental rationality around the world would suggest any … governments should bear the cost of the expected increased industry obsolescence determined by a temporary patent waiver; this … includes public patent-buy-outs and regulated public-private R&D partnerships. …

years a patent is renewed and the number of countries in which protection for the same invention is sought - can be used to …Patent counts are very imperfect measures of innovative output. This paper discusses how additional data-the number of … improve on counts in studies which require a measure of the extent of innovation. A simple renewal based weighting scheme is …

-effects regressions, this study yields robust results. National patent protection alone does not stimulate domestic innovation, as …This paper evaluates the effects of patent protection on pharmaceutical innovations for twenty-six countries that … established pharmaceutical patent laws during 1978-2002. Controlling for country characteristics through matched sampling …